(Q33960952)

30 July 2017

title

Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA. (English)

1 reference

30 July 2017

author

Grzegorz K Przybylski

7

object named as

Grzegorz K Przybylski

1 reference

30 July 2017

6

Piotr Grabarczyk

1 reference

30 July 2017

Xin Huang

1

1 reference

30 July 2017

Si Chen

2

1 reference

30 July 2017

Qi Shen

3

1 reference

30 July 2017

Shaohua Chen

4

1 reference

30 July 2017

Lijian Yang

5

1 reference

30 July 2017

Christian A Schmidt

8

1 reference

30 July 2017

Yangqiu Li

9

1 reference

30 July 2017

publication date

1 July 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

16

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

236-242

1 reference

Receptor-directed therapy of T-cell leukemias and lymphomas

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

Alemtuzumab in CLL and other lymphoid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

CCR4 as a novel molecular target for immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

CD26 regulates p38 mitogen-activated protein kinase-dependent phosphorylation of integrin beta1, adhesion to extracellular matrix, and tumorigenicity of T-anaplastic large cell lymphoma Karpas 299.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

Protein kinase C-theta (PKCtheta), a potential drug target for therapeutic intervention with human T cell leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

siRNA delivery systems for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

siRNA-based approaches in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

Knocking down barriers: advances in siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

Bcl11b is required for differentiation and survival of αβ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

Critical roles of Bcl11b in T-cell development and maintenance of T-cell identity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

Bcl11b mutations identified in murine lymphomas increase the proliferation rate of hematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

Oncogene suppression by small interfering RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

Isolation of a novel family of C(2)H(2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32)

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F102453311X13025568941961

10.1179/102453311X13025568941961

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference